Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Conrad Fafard is a leading developer and manufacturer of professional-grade growing media, peat moss, and bark-based substrates for the horticultural industry. Founded in 1929, the company provides high-quality soil mixes and amendments designed to optimize plant growth in commercial greenhouses and nurseries. In 2012, the company was acquired by Syngenta, integrating its substrate expertise into Syngenta's global agricultural and ornamental plant portfolio. Today, the Fafard brand remains a staple for professional growers seeking specialized media for seed starting, propagation, and crop production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Conrad Fafard.